BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Staging
5 results:

  • 1. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
    Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
    J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Alterations and the Incidence of brain Metastases in Advanced and Metastatic NSCLC: A Systematic Review and Meta-Analysis.
    Gillespie CS; Mustafa MA; Richardson GE; Alam AM; Lee KS; Hughes DM; Escriu C; Zakaria R
    J Thorac Oncol; 2023 Dec; 18(12):1703-1713. PubMed ID: 37392903
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TNM staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
    Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing.
    Mancini L; Casagranda S; Gautier G; Peter P; Lopez B; Thorne L; McEvoy A; Miserocchi A; Samandouras G; Kitchen N; Brandner S; De Vita E; Torrealdea F; Rega M; Schmitt B; Liebig P; Sanverdi E; Golay X; Bisdas S
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2377-2391. PubMed ID: 35029738
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Management of brain Metastases in ALK-Positive Non-Small-Cell Lung cancer.
    Rusthoven CG; Doebele RC
    J Clin Oncol; 2016 Aug; 34(24):2814-9. PubMed ID: 27298405
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.